CALC vs JLL · $22.5M cap vs P/E 23, rev $13.31B
CalciMedica, Inc. Common Stock (CALC) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
CalciMedica, Inc. Common Stock (CALC) is a biotechnology company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
CALC does not have a complete income-statement cache yet.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
CALC currently screens at market cap $22.5M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the CALC and JLL stock pages for the full models.
Not investment advice.